Look for:

Our offer for

BIOGEN IDEC INC.


ISIN:
US09062X1037
WKN:
09062X103

2020/11/27 19:00:00
Price
243.78 USD
Difference 0.84% (2.03)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)31,496 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)243.11 USD (100)
Ask (Ask size)243.78 USD (800)
Open242.00 USD
High244.33 USD
Low241.00 USD
Close (prev. day)241.75 USD
VWAP243.013387 USD
Volume (pcs)699,227
Trading volume169,919,853.47
Number of trades12,864
Last size81,914

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: BIOGEN IDEC INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Erste Group related products on underlying

Product type # products
Express bonds 1

Recent research



2020/11/27 19:00:00
Price
243.78 USD
Difference 0.84% (2.03)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)31,496 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)243.11 USD (100)
Ask (Ask size)243.78 USD (800)
Open242.00 USD
High244.33 USD
Low241.00 USD
Close (prev. day)241.75 USD
VWAP243.013387 USD
Volume (pcs)699,227
Trading volume169,919,853.47
Number of trades12,864
Last size81,914

Performance and Risk

6M1Y3Y
Perf (%)-20.62%-20.11%-21.76%
Perf (abs.)-62.78-60.86-67.22
Beta1.070.880.88
Volatility61.9758.2248.45
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)243.16 USD (1,307,404)
Ø price 30 days | Ø volume 30 days (pcs.)249.83 USD (2,228,610)
Ø price 100 days | Ø volume 100 days (pcs.)271.37 USD (1,489,539)
Ø price 250 days | Ø volume 250 days (pcs.)288.80 USD (1,745,544)
YTD High | date374.99 USD (2020/02/05)
YTD Low | date223.25 USD (2020/11/09)
52 Weeks High | date374.99 USD (2020/02/05)
52 Weeks Low | date223.25 USD (2020/11/09)

Erste Group related products on underlying

Product type # products
Express bonds 1

All listings for BIOGEN IDEC INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2020/11/2717:35203.95 EUR0.1035
Vienna Stock Exchange2020/11/2717:32203.55 EUR0.039
Tradegate2020/11/2722:26203.45 EUR0.4351
Stuttgart2020/11/2718:54203.55 EUR0.016
SIX Swiss Exchange2019/07/0217:35232.00 CHF0.001
Nasdaq2020/11/2719:00243.78 USD169.9212,864
Munich2020/11/2708:00203.50 EUR0.002
London Stock Exchange2020/11/1715:39253.9865 USD0.002
Hanover2020/11/2708:02201.85 EUR0.002
Hamburg2020/11/2709:07204.30 EUR0.002
Frankfurt2020/11/2715:53202.65 EUR0.012
Duesseldorf2020/11/2719:30203.15 EUR0.0023
Berlin2020/11/2719:35203.95 EUR0.0016

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2033&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIOGEN INC.
Joe Mara
Binney Street 225 02142 Cambridge, Massachusetts
Telefon: +1-671-679-2000
Fax: +1-617-679-2617
E-mail: IR@biogenidec.com

PDF Downloads

Annual report: BIOGEN IDEC INC.PDF Download

Company Profile

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world's oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies.

Members of Management Board

Stelios PapadopoulosChairman of Board of Directors
William A. HawkinsMember of Board of Directors
Stephen A. SherwinMember of Board of Directors
Robert W. PangiaMember of Board of Directors
Nancy L. LeamingMember of Board of Directors
Michel VounatsosMember of Board of Directors
Jesus B. MantasMember of Board of Directors
Eric K. RowinskyMember of Board of Directors
Caroline DorsaMember of Board of Directors
Brian S. PosnerMember of Board of Directors
Richard C. MulliganMember of Board of Directors
Alexander J. DennerMember of Board of Directors
Michel VounatsosChairman of Managing Board
Susan H. AlexanderMember of Executive Committee
Michael McDonnellMember of Executive Committee
Chirfi GuindoMember of Executive Committee
Alphonse GaldesMember of Executive Committee
Alfred SandrockMember of Executive Committee
Ginger GregoryMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.